You are here

  • Home
  • Archive
  • Volume 9, Issue Suppl 2
  • 382 The synthetic long peptide cancer vaccine UV1 in combination with ipilimumab induces a CD4+ Th1 anti-hTERT immune response and an inflammatory tumor microenvironment in patients with melanoma

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Clinical Trials Completed
382 The synthetic long peptide cancer vaccine UV1 in combination with ipilimumab induces a CD4+ Th1 anti-hTERT immune response and an inflammatory tumor microenvironment in patients with melanoma
Free

 

Online download statistics by month:

Online download statistics by month: November 2021 to September 2024

AbstractFullPdf
Nov 2021377027
Dec 20218007
Jan 20226805
Feb 20226603
Mar 202225203
Apr 20227207
May 20223409
Jun 20223206
Jul 20222801
Aug 20223002
Sep 20222407
Oct 20222205
Nov 20221604
Dec 20223201
Jan 20231604
Feb 20231402
Mar 20231201
Apr 20231401
May 20231804
Jun 20231400
Jul 20232010
Aug 2023805
Sep 2023600
Oct 20231602
Nov 20232207
Dec 20233603
Jan 20242200
Feb 20241802
Mar 202444021
Apr 20242004
May 20242406
Jun 20242607
Jul 20241204
Aug 20241602
Sep 20241207
Total15050179